PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.00 - 0.01
0.00 - 0.02
289 / 496.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-100.00%
Negative revenue growth while ECL.AX stands at 0.00%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-100.00%
Negative gross profit growth while ECL.AX is at 0.00%. Joel Greenblatt would examine cost competitiveness or demand decline.
100.00%
EBIT growth of 100.00% while ECL.AX is zero. Bruce Berkowitz would see if small gains can be scaled further.
100.00%
Operating income growth of 100.00% while ECL.AX is zero. Bruce Berkowitz would see if this modest edge can become significant.
100.00%
Net income growth of 100.00% while ECL.AX is zero. Bruce Berkowitz would see if small gains can accelerate into a larger gap.
100.00%
EPS growth of 100.00% while ECL.AX is zero. Bruce Berkowitz would see if minimal gains can accelerate over time.
100.00%
Diluted EPS growth of 100.00% while ECL.AX is zero. Bruce Berkowitz would see if minimal gains can be scaled further for a bigger lead.
-100.00%
Share reduction while ECL.AX is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Negative 10Y revenue/share CAGR while ECL.AX stands at 147.61%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
100.00%
10Y OCF/share CAGR under 50% of ECL.AX's 440.38%. Michael Burry would worry about a persistent underperformance in cash creation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Our R&D shrinks while ECL.AX invests at 0.00%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-100.00%
We cut SG&A while ECL.AX invests at 0.00%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.